A stable core–shell spherical “storage pool” was obtained, which could realize the combination of chemodynamic, microwave dynamic and microwave thermal therapy.
Thermotherapy can directly kill tumor cells whilst being accompanied by immune‐enhancing effects. However, this immune‐enhancing effect suffers from insufficient expression of immune response factors (e.g., heat shock protein 70, HSP70), resulting in no patient benefiting due to the recurrence of tumor cells after thermotherapy. Herein, a nanoengineered strategy of programmed upregulating of the immune response factors for amplifying synergistic therapy is explored. Metal‐organic frameworks nanoamplifiers (teprenone/nitrocysteine@ZrMOF‐NH2@L‐menthol@triphenylphosphine, GGA/CSNO@ZrMOF‐NH2‐LM‐TPP nanoamplifier, and GCZMT nanoamplifier) achieve excellent microwave (MW) thermal‐immunotherapy by programmed induction of HSP70 expression. After intravenous administration, GCZMT nanoamplifiers target the mitochondria, and then release nitric oxide (NO) under MW irradiation. NO inhibits the growth of tumor cells by interfering with the energy supply of cells. Subsequently, under the combination of MW, NO, and GGA, HSP70 expression can be programmed upregulated, which can induce the response of cytotoxic CD4+ T cells and CD8+ T cells, and effectively activate antitumor immunotherapy. Hence, GCZMT nanoamplifier‐mediated MW therapy can achieve a satisfactory therapeutic effect with the tumor inhibition of 97%. This research offers a distinctive insight into the exploitation of metal‐organic frameworks nanoamplifiers for enhanced tumor therapy, which provides a new approach for highly effective cancer treatment.
Cisplatin (CDDP) is a widely used chemotherapeutic drug
with proven
efficacy for treating tumors. However, its use has been associated
with severe side effects and eventually leads to drug resistance,
thus limiting its clinical application in patients with ovarian cancer
(OC). Herein, we aimed to investigate the success rate of reversing
cisplatin resistance using a synthetic, multitargeted nanodrug delivery
system comprising a Mn-based metal–organic framework (Mn-MOF)
containing niraparib (Nira) and CDDP alongside transferrin (Tf) conjugated
to the surface (Tf-Mn-MOF@Nira@CDDP; MNCT). Our results revealed that
MNCT can target the tumor site, consume glutathione (GSH), which is
highly expressed in drug-resistant cells, and then decompose to release
the encapsulated Nira and CDDP. Nira and CDDP play a synergistic role
in increasing DNA damage and apoptosis, exhibiting excellent antiproliferation,
migration, and invasion activities. In addition, MNCT significantly
inhibited tumor growth in tumor-bearing mice and exhibited excellent
biocompatibility without side effects. Furthermore, it depleted GSH,
downregulated multidrug-resistant transporter protein (MDR) expression, and upregulated tumor suppressor protein phosphatase
and tensin homolog (PTEN) expression, consequently
reducing DNA damage repair and reversing cisplatin resistance. These
results indicate that multitargeted nanodrug delivery systems can
provide a promising clinical approach to overcoming cisplatin resistance.
This study provides an experimental basis for further investigation
into multitargeted nanodrug delivery systems to reverse cisplatin
resistance in patients with OC.
Backgrounds
Microwave sensitization nanoplatform, integrating multiple functional units for improving tumor selectivity, is of great significance for clinical tumor microwave treatment. Lanthanide europium metal organic framework (EuMOF) is expected to be a theranostic nanoplatform owing to its unique luminescent and microwave sensitization properties. However, it is difficult to be applied to complicated biological systems for EuMOF due to its rapid degradation induced by the solvent molecular and ionic environment. In this work, a luminescent EuMOF nanocomposite (EuMOF@ZIF/AP-PEG, named EZAP) was designed, which brought the multifunctional characteristics of microwave sensitization, fluorescence imaging and drug loading.
Results
Lamellar EuMOF was synthesized by a hydrothermal method. Through the charge adsorption mechanism, the zeolite imidazole framework (ZIF) structure was intensively assembled on the surface of EuMOF to realize the protection. Then, through in-situ Apatinib drug loading and PEG modification, EZAP nanocomposite was finally obtained. Apatinib (AP) was a kind of chemotherapy drug approved by Food and Drug Administration for targeted therapy of tumors. PEG modification increased long-term circulation of EZAP nanocomposite. The physical and chemical structure and properties of EuMOF@ZIF (EZ) were systematically represented, indicating the successful synthesis of the nanocomposite. The toxic and side effects were negligible at a safe dose. The growth of human liver cancer cells and murine liver cancer cells in vitro was significantly inhibited, and the combined microwave-thermal therapy and chemotherapy in vivo achieved high anti-cancer efficacy. Moreover, EZAP nanocomposite possessed bright red fluorescence, which can be applied for tumor imaging in tumor-bearing mice in vivo.
Conclusion
Therefore, EZAP nanocomposite showed high microwave sensitization, excellent fluorescence properties and outstanding drug loading capacity, establishing a promising theranostic nanoplatform for tumor therapy and fluorescence imaging. This work proposes a unique strategy to design for the first time a multifunctional nanoplatform with lanthanide metal organic frameworks for biological applications in tumor therapy and diagnosis.
Graphical Abstract
Microwave hyperthermia is an emerging minimally invasive therapy in which thermal damage and apoptosis of tumor cells are induced by local heating of tissues with microwave radiation. Recently, microwave hyperthermia has been widely used in clinical practice; however, uneven aggregation and dispersion of malignant tumors after microwave hyperthermia are the main problems associated with this method. In this work, a microridged waveguide tumor hyperthermia antenna with an operating frequency of 915 MHz was designed. Although its volume is only 6.6 cm 3 , it exhibited a highly focused heating effect, achieving rapid heating in a small area. However, microwave hyperthermia has several shortcomings. Microwaves cannot specifically identify and target tumors; this decreases the efficiency of the treatment if the temperature of the tumor site is not sufficiently high for its size and location. Therefore, Zr metal−organic framework (ZrMOF)-derived composite ZCNC was synthesized using the ultrasonic aerosol flow method, which has good microwave sensitization and biosafety. ZCNC reduced the damage to normal cells and greatly improved the tumor treatment effect of microwave hyperthermia (tumor inhibition rate reached 78.01%). Thus, the proposed strategy effectively improves the current clinical microwave hyperthermia treatment method.
Hollow materials derived from metal–organic frameworks
(MOFs)
have emerged in the biomedical field due to their unique properties,
and different synthesis methods have been proposed. However, so far,
the large-scale use of hollow MOFs is mostly limited by the timeliness
of synthesis methods. Herein, we propose a new ultrasonic aerosol
flow strategy for the instantaneous synthesis of a Zr-MOF-derived
hollow sphere complex (ZC-HSC) in only one step. Through rapid transient
heating, the coordination between metal salts and organic ligands
occurs along with prompt evaporation of the solvent. The whole process
lasts for only about 21 s, compared with several steps that take hours
or even days for conventional synthesis methods. Based on the ZC-HSC,
we designed a nanodrug with the functions of manipulating the tumor
microenvironment, which can reshape the tumor microenvironment by
improving tumor hypoxia and inflammatory microenvironment and promoting
antiangiogenic therapy. Combined with microwave thermo-chemotherapy,
the nanodrugs effectively treat triple-negative breast cancer (the
tumor cell survival rate was only 34.76 and 31.05% in normoxic and
hypoxic states, respectively, and the tumor inhibition rate reached
87.9% at the animal level), providing a new theoretical basis for
the treatment of triple-negative breast cancer. This rapid, one-step,
and continuous ultrasonic aerosol flow strategy has bright prospects
in the synthesis of MOF-derived hollow materials and promotes the
further development of large-scale applications of biological nanomaterials.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.